                         SEQUENCE LISTING

<110>  THE UNIVERSITY OF VERMONT AND STATE AGRICULTURE COLLEGE
 
<120>  METHODS FOR SELECTING AN INTRACRANIAL ATHEROSCLEROTIC DISEASE 
       PATIENT FOR TREATMENT

<130>  167914.011700PCT

<140>  PCT/US2021/044439
<141>  2021-08-04

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Val Val Tyr Thr Asp Cys Thr Glu Ser Gly Gln Asn Leu Cys Leu Cys 
1               5                   10                  15      


Glu Gly Ser Asn Val Cys Gly Gln Gly Asn Lys Cys Ile Leu Gly Ser 
            20                  25                  30          


Asp Gly Glu Lys Asn Gln Cys Val Thr Gly Glu Gly Thr Pro Lys Pro 
        35                  40                  45              


Gln Ser His Asn Asp Gly Asp Phe Glu Glu Ile Pro Glu Glu Tyr Leu 
    50                  55                  60                  


Gln 
65  


<210>  2
<211>  355
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Ser Tyr Gln Gly Asn Ser Asp Cys Tyr Phe Gly Asn Gly Ser Ala Tyr 
1               5                   10                  15      


Arg Gly Thr His Ser Leu Thr Glu Ser Gly Ala Ser Cys Leu Pro Trp 
            20                  25                  30          


Asn Ser Met Ile Leu Ile Gly Lys Val Tyr Thr Ala Gln Asn Pro Ser 
        35                  40                  45              


Ala Gln Ala Leu Gly Leu Gly Lys His Asn Tyr Cys Arg Asn Pro Asp 
    50                  55                  60                  


Gly Asp Ala Lys Pro Trp Cys His Val Leu Lys Asn Arg Arg Leu Thr 
65                  70                  75                  80  


Trp Glu Tyr Cys Asp Val Pro Ser Cys Ser Thr Cys Gly Leu Arg Gln 
                85                  90                  95      


Tyr Ser Gln Pro Gln Phe Arg Ile Lys Gly Gly Leu Phe Ala Asp Ile 
            100                 105                 110         


Ala Ser His Pro Trp Gln Ala Ala Ile Phe Ala Lys His Arg Arg Ser 
        115                 120                 125             


Pro Gly Glu Arg Phe Leu Cys Gly Gly Ile Leu Ile Ser Ser Cys Trp 
    130                 135                 140                 


Ile Leu Ser Ala Ala His Cys Phe Gln Glu Arg Phe Pro Pro His His 
145                 150                 155                 160 


Leu Thr Val Ile Leu Gly Arg Thr Tyr Arg Val Val Pro Gly Glu Glu 
                165                 170                 175     


Glu Gln Lys Phe Glu Val Glu Lys Tyr Ile Val His Lys Glu Phe Asp 
            180                 185                 190         


Asp Asp Thr Tyr Asp Asn Asp Ile Ala Leu Leu Gln Leu Lys Ser Asp 
        195                 200                 205             


Ser Ser Arg Cys Ala Gln Glu Ser Ser Val Val Arg Thr Val Cys Leu 
    210                 215                 220                 


Pro Pro Ala Asp Leu Gln Leu Pro Asp Trp Thr Glu Cys Glu Leu Ser 
225                 230                 235                 240 


Gly Tyr Gly Lys His Glu Ala Leu Ser Pro Phe Tyr Ser Glu Arg Leu 
                245                 250                 255     


Lys Glu Ala His Val Arg Leu Tyr Pro Ser Ser Arg Cys Thr Ser Gln 
            260                 265                 270         


His Leu Leu Asn Arg Thr Val Thr Asp Asn Met Leu Cys Ala Gly Asp 
        275                 280                 285             


Thr Arg Ser Gly Gly Pro Gln Ala Asn Leu His Asp Ala Cys Gln Gly 
    290                 295                 300                 


Asp Ser Gly Gly Pro Leu Val Cys Leu Asn Asp Gly Arg Met Thr Leu 
305                 310                 315                 320 


Val Gly Ile Ile Ser Trp Gly Leu Gly Cys Gly Gln Lys Asp Val Pro 
                325                 330                 335     


Gly Val Tyr Thr Lys Val Thr Asn Tyr Leu Asp Trp Ile Arg Asp Asn 
            340                 345                 350         


Met Arg Pro 
        355 


<210>  3
<211>  317
<212>  PRT
<213>  Homo sapiens


<220>
<221>  SITE
<222>  (1)..(317)
<223>  FcyRIIa protein

<400>  3

Met Thr Met Glu Thr Gln Met Ser Gln Asn Val Cys Pro Arg Asn Leu 
1               5                   10                  15      


Trp Leu Leu Gln Pro Leu Thr Val Leu Leu Leu Leu Ala Ser Ala Asp 
            20                  25                  30          


Ser Gln Ala Ala Ala Pro Pro Lys Ala Val Leu Lys Leu Glu Pro Pro 
        35                  40                  45              


Trp Ile Asn Val Leu Gln Glu Asp Ser Val Thr Leu Thr Cys Gln Gly 
    50                  55                  60                  


Ala Arg Ser Pro Glu Ser Asp Ser Ile Gln Trp Phe His Asn Gly Asn 
65                  70                  75                  80  


Leu Ile Pro Thr His Thr Gln Pro Ser Tyr Arg Phe Lys Ala Asn Asn 
                85                  90                  95      


Asn Asp Ser Gly Glu Tyr Thr Cys Gln Thr Gly Gln Thr Ser Leu Ser 
            100                 105                 110         


Asp Pro Val His Leu Thr Val Leu Ser Glu Trp Leu Val Leu Gln Thr 
        115                 120                 125             


Pro His Leu Glu Phe Gln Glu Gly Glu Thr Ile Met Leu Arg Cys His 
    130                 135                 140                 


Ser Trp Lys Asp Lys Pro Leu Val Lys Val Thr Phe Phe Gln Asn Gly 
145                 150                 155                 160 


Lys Ser Gln Lys Phe Ser His Leu Asp Pro Thr Phe Ser Ile Pro Gln 
                165                 170                 175     


Ala Asn His Ser His Ser Gly Asp Tyr His Cys Thr Gly Asn Ile Gly 
            180                 185                 190         


Tyr Thr Leu Phe Ser Ser Lys Pro Val Thr Ile Thr Val Gln Val Pro 
        195                 200                 205             


Ser Met Gly Ser Ser Ser Pro Met Gly Ile Ile Val Ala Val Val Ile 
    210                 215                 220                 


Ala Thr Ala Val Ala Ala Ile Val Ala Ala Val Val Ala Leu Ile Tyr 
225                 230                 235                 240 


Cys Arg Lys Lys Arg Ile Ser Ala Asn Ser Thr Asp Pro Val Lys Ala 
                245                 250                 255     


Ala Gln Phe Glu Pro Pro Gly Arg Gln Met Ile Ala Ile Arg Lys Arg 
            260                 265                 270         


Gln Leu Glu Glu Thr Asn Asn Asp Tyr Glu Thr Ala Asp Gly Gly Tyr 
        275                 280                 285             


Met Thr Leu Asn Pro Arg Ala Pro Thr Asp Asp Asp Lys Asn Ile Tyr 
    290                 295                 300                 


Leu Thr Leu Pro Pro Asn Asp His Val Asn Ser Asn Asn 
305                 310                 315         


<210>  4
<211>  2429
<212>  DNA
<213>  Homo sapiens


<220>
<221>  misc_feature
<222>  (1)..(2429)
<223>  FcyRIIa polynucleotide

<400>  4
ctcttttcta agcttgtctc ttaaaaccca ctggacgttg gcacagtgct gggatgacta       60

tggagaccca aatgtctcag aatgtatgtc ccagaaacct gtggctgctt caaccattga      120

cagttttgct gctgctggct tctgcagaca gtcaagctgc agctccccca aaggctgtgc      180

tgaaacttga gcccccgtgg atcaacgtgc tccaggagga ctctgtgact ctgacatgcc      240

agggggctcg cagccctgag agcgactcca ttcagtggtt ccacaatggg aatctcattc      300

ccacccacac gcagcccagc tacaggttca aggccaacaa caatgacagc ggggagtaca      360

cgtgccagac tggccagacc agcctcagcg accctgtgca tctgactgtg ctttccgaat      420

ggctggtgct ccagacccct cacctggagt tccaggaggg agaaaccatc atgctgaggt      480

gccacagctg gaaggacaag cctctggtca aggtcacatt cttccagaat ggaaaatccc      540

agaaattctc ccatttggat cccaccttct ccatcccaca agcaaaccac agtcacagtg      600

gtgattacca ctgcacagga aacataggct acacgctgtt ctcatccaag cctgtgacca      660

tcactgtcca agtgcccagc atgggcagct cttcaccaat ggggatcatt gtggctgtgg      720

tcattgcgac tgctgtagca gccattgttg ctgctgtagt ggccttgatc tactgcagga      780

aaaagcggat ttcagccaat tccactgatc ctgtgaaggc tgcccaattt gagccacctg      840

gacgtcaaat gattgccatc agaaagagac aacttgaaga aaccaacaat gactatgaaa      900

cagctgacgg cggctacatg actctgaacc ccagggcacc tactgacgat gataaaaaca      960

tctacctgac tcttcctccc aacgaccatg tcaacagtaa taactaaaga gtaacgttat     1020

gccatgtggt catactctca gcttgctgag tggatgacaa aaagagggga attgttaaag     1080

gaaaatttaa atggagactg gaaaaatcct gagcaaacaa aaccacctgg cccttagaaa     1140

tagctttaac tttgcttaaa ctacaaacac aagcaaaact tcacggggtc atactacata     1200

caagcataag caaaacttaa cttggatcat ttctggtaaa tgcttatgtt agaaataaga     1260

caaccccagc caatcacaag cagcctacta acatataatt aggtgactag ggactttcta     1320

agaagatacc tacccccaaa aaacaattat gtaattgaaa accaaccgat tgcctttatt     1380

ttgcttccac attttcccaa taaatacttg cctgtgacat tttgccactg gaacactaaa     1440

cttcatgaat tgcgcctcag atttttcctt taacatcttt tttttttttg acagagtctc     1500

aatctgttac ccaggctgga gtgcagtggt gctatcttgg ctcactgcaa acccgcctcc     1560

caggtttaag cgattctcat gcctcagcct cccagtagct gggattagag gcatgtgcca     1620

tcatacccag ctaatttttg tattttttat tttttttttt tagtagagac agggtttcgc     1680

aatgttggcc aggccgatct cgaacttctg gcctctagcg atctgcccgc ctcggcctcc     1740

caaagtgctg ggatgaccag catcagcccc aatgtccagc ctctttaaca tcttctttcc     1800

tatgccctct ctgtggatcc ctactgctgg tttctgcctt ctccatgctg agaacaaaat     1860

cacctattca ctgcttatgc agtcggaagc tccagaagaa caaagagccc aattaccaga     1920

accacattaa gtctccattg ttttgccttg ggatttgaga agagaattag agaggtgagg     1980

atctggtatt tcctggacta aattcccctt ggggaagacg aagggatgct gcagttccaa     2040

aagagaagga ctcttccaga gtcatctacc tgagtcccaa agctccctgt cctgaaagcc     2100

acagacaata tggtcccaaa tgactgactg caccttctgt gcctcagccg ttcttgacat     2160

caagaatctt ctgttccaca tccacacagc caatacaatt agtcaaacca ctgttattaa     2220

cagatgtagc aacatgagaa acgcttatgt tacaggttac atgagagcaa tcatgtaagt     2280

ctatatgact tcagaaatgt taaaatagac taacctctaa caacaaatta aaagtgattg     2340

tttcaaggtg atgcaattat tgatgaccta ttttattttt ctataatgat catatattac     2400

ctttgtaata aaacattata accaaaaca                                       2429


